Notice of AGM | 03-Oct-2025 | 07:00 | RNS |
Director Dealing | 16-Sep-2025 | 07:00 | RNS |
Final Results | 11-Sep-2025 | 07:00 | RNS |
Notice of Results | 04-Sep-2025 | 07:00 | RNS |
Director Dealing | 08-Aug-2025 | 12:31 | RNS |
Director/PDMR Shareholding | 04-Aug-2025 | 10:23 | RNS |
Strong Phase 2 data on iSCIB1+ in Melanoma | 22-Jul-2025 | 07:00 | RNS |
Share Option Exercise | 16-Jul-2025 | 07:00 | RNS |
Scancell initiates new arm in SCOPE Phase 2 study | 25-Jun-2025 | 07:00 | RNS |
Director Dealing | 21-May-2025 | 07:00 | RNS |
Partnership with NHS Cancer Vaccine Launch Pad | 14-Apr-2025 | 07:00 | RNS |
Scancell to present at 2025 AACR Annual Meeting | 01-Apr-2025 | 07:00 | RNS |
Issue of share options | 20-Feb-2025 | 07:00 | RNS |
Scancell presenting at AACR IO conference | 17-Feb-2025 | 07:00 | RNS |
Interim Results | 30-Jan-2025 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 9.55p |
Change Today | -0.20p |
% Change | -2.05 % |
52 Week High | 16.50p |
52 Week Low | 7.50p |
Volume | 326,171 |
Shares Issued | 1,037.78m |
Market Cap | £99.11m |
Value | ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
16:28 | 12,729 @ 9.82p |
15:27 | 20,000 @ 9.57p |
15:23 | 5,488 @ 9.84p |
14:44 | 14,001 @ 9.57p |
12:45 | 3,480 @ 9.57p |
CFO | Sath Nirmalananthan |
CEO | Phil L'Huillier |
You are here: research